|
Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, Garrido-Bravo I, Pastor-Perez F, Diez J, Ibanez B, Lax A. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol. 2019 Mar 12;73(9):1016-1025. doi: 10.1016/j.jacc.2018.11.054. PubMed PMID: 30846095.
AÑO: 2019; IF: 20.589
|
|
Lopez, MCA; Oltra-Rodriguez, L; Garcia-Carrillo, N; Saura-Guillen, E; Sanchez-Perez, MCA; Hernandez-Vicente, A; Martinez-Herrera, M; Lopez-Herrera, P; Pascual-Figal, DA; Lax, AMAM. Pharmacological mitochondrial stabilization to prevents adverse cardiac remodeling following MI using empagliflozin. EUROPEAN JOURNAL OF HEART FAILURE. 2019; 21:321-321.
AÑO: 2019; IF: 11.627
|
|
Sanchez-Mas J, Saura-Guillen E, Asensio-Lopez MC, Soriano-Filiu A, Carmen Sanchez-Perez M, Hernandez-Martinez AM, Lax A, Pascual-Figal D. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction. Diabetes Metab. 2019 Apr;45(2):201-204. doi: 10.1016/j.diabet.2017.09.008. Epub 2017 Oct 31. No abstract available. PubMed PMID: 29097004.
AÑO: 2019; IF: 4.731
|
|
Ponikowski P, Kirwan BA, Anker SD, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Haboubi T, Keren A, Khintibidze I, Kragten H, Martinez FA, McDonagh T, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Jankowska EA. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. Eur J Heart Fail. 2019 Dec;21(12):1651-1658. doi: 10.1002/ejhf.1710. Epub 2019 Dec 28. PubMed PMID: 31883356.
AÑO: 2019; IF: 11.627
|
|
Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world. Eur J Heart Fail. 2019 Nov;21(11):1383-1397. doi: 10.1002/ejhf.1532. Epub 2019 Jun 18. PubMed PMID: 31132222.
AÑO: 2019; IF: 11.627
|